Evidence map›Paper›PMID 38982500›Full record

ArticleOrphanet journal of rare diseases2024

Essential components of an effective transition from paediatric to adult neurologist care for adolescents with Duchenne muscular dystrophy; a consensus derived using the Delphi methodology in Eastern Europe, Greece and Israel.

Maria Judit Molnar, Léna Szabó, Oana Aurelia Vladacenco, Ana Maria Cobzaru, Talya Dor, Amir Dori, Georgios Papadimas, Lenka Juříková, Ivan Litvinenko, Ivailo Tournev and 1 more

Abstract readConsensus Statement
In one paragraph

Article in Orphanet journal of rare diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Maria Judit MolnarDirector of Institute of Genomic Medicine and Rare Disorders, Semmelweis University, Budapest, Hungary.
Léna SzabóPediatric Center, Semmelweis University, Budapest, Hungary.
Oana Aurelia VladacencoUniversity of Medicine and Pharmacy Bucharest, Bucharest, Romania.
Ana Maria CobzaruUniversity Emergency Hospital Bucharest, Bucharest, Romania.
Talya DorPediatric Neurology Unit, Hadassah University Hospital, Jerusalem, Israel.
Amir DoriSheba Medical Center at Tel-Hashomer, Neurology Clinic, Ramat-Gan, Israel.
Georgios PapadimasFirst Department of Neurology, University of Athens, Athens, Greece.
Lenka JuříkováDepartment of Pediatric Neurology, University Hospital Brno, Brno, Czech Republic.
Ivan LitvinenkoPediatric Neurology Department, SHATPD "Prof. Dr. Ivan Mitev", Sofia, Bulgaria.
Ivailo TournevDepartment of Neurology, University Hospital Aleksandrovska, Medical University, Sofia, Bulgaria.
Craig DixonMASS Team, London, UK. craig@mass-team.com.ORCID 0009-0008-6957-5693

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAn increasing number of patients with Duchenne muscular dystrophy (DMD) now have access to improved standard of care and disease modifying treatments, which improve the clinical course of DMD and extend life expectancy beyond 30 years of age. A key issue for adolescent DMD patients is the transition from paediatric- to adult-oriented healthcare. Adolescents and adults with DMD have unique but highly complex healthcare needs associated with long-term steroid use, orthopaedic, respiratory, cardiac, psychological, and gastrointestinal problems meaning that a comprehensive transition process is required. A sub-optimal transition into adult care can have disruptive and deleterious consequences for a patient's long-term care. This paper details the results of a consensus amongst clinicians on transitioning adolescent DMD patients from paediatric to adult neurologists that can act as a guide to best practice to ensure patients have continuous comprehensive care at every stage of their journey.

methodsThe consensus was derived using the Delphi methodology. Fifty-three statements were developed by a Steering Group (the authors of this paper) covering seven topics: Define the goals of transition, Preparing the patient, carers/parents and the adult centre, The transition process at the paediatric centre, The multidisciplinary transition summary - Principles, The multidisciplinary transition summary - Content, First visit in the adult centre, Evaluation of transition. The statements were shared with paediatric and adult neurologists across Central Eastern Europe (CEE) as a survey requesting their level of agreement with each statement.

resultsData from 60 responders (54 full responses and six partial responses) were included in the data set analysis. A consensus was agreed across 100% of the statements.

conclusionsIt is hoped that the findings of this survey which sets out agreed best practice statements, and the transfer template documents developed, will be widely used and so facilitate an effective transition from paediatric to adult care for adolescents with DMD.

Indexed as

Delphi TechniqueMuscular Dystrophy, DuchenneAdolescentAdultChildEuropeFemaleGreeceHumansIsraelMaleNeurologistsTransition to Adult CareAdolescentsDelphiDMDDuchenne muscular dystrophyLife expectancyTransition

Identifiers

PMID38982500
PMCPMC11234532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.